Journal of Chinese Integrative Medicine ›› 2010, Vol. 8 ›› Issue (3): 201-209.doi: 10.3736/jcim20100301
• Review • Next Articles
Ping Xie, Xin-xi Zhou, Qin Zhang
[1] | Pan AQ . The role of insulin resistance and leptin in non-alcoholic fatty liver disease[J]. Zhongguo Yi Yao Dao Kan, 2008,10(3):400-401 |
潘爱群 . 胰岛素抵抗、瘦素在非酒精性脂肪肝发病中的作用[J]. 中国医药导刊, 2008,10(3):400-401 | |
[2] | Frayn KN . Visceral fat and insulin resistence: causative or correlative?[J]. Br J Nutr, 2000,83(Suppl 1):S71-S77 |
[3] | Petta S, Camma C, Marco VD, Alessi N, Barbaria F, Cabibi D, Caldarella R, Ciminnisi S, Licata A, Massenti MF, Mazzola A, Tarantino G, Marchesini G, Crax A . Retinol-binding protein 4: a new marker of virus-induced steatosis in patients infected with HCV genotype 1[J]. Hepatology, 2008,48(1):28-37 |
[4] |
Yang Q, Graham TE, Mody N, Preitner F, Peroni OD, Zabolotny JM, Kotani K, Quadro L, Kahn BB . Serum retinol binding protein 4 contributes to insulin resistance in obesity and type 2 diabetes[J]. Nature, 2005,436(7049):356-362
doi: 10.1038/nature03711 |
[5] |
Shiota G . Loss of function of retinoic acid in liver leads to steatohepatitis and liver tumor: A NASH animal model[J]. Hepatol Res, 2005,33(2):155-160
doi: 10.1016/j.hepres.2005.09.025 |
[6] |
Maher JJ, Leon P, Ryan JC . Beyong insulin resistance: innate immunity in nonalcoholic steatohepatitis[J]. Hepatology, 2008,48(2):670-678
doi: 10.1002/hep.v48:2 |
[7] | Ma X . Metabolic nuclear receptors: a new target for therapy of non-alcoholic fatty liver disease[J]. Guo Ji Xiao Hua Bing Za Zhi, 2008,28(2):91-93 |
马雄 . 代谢性核受体: 非酒精性脂肪性肝病治疗的新靶点[J]. 国际消化病杂志, 2008,28(2):91-93 | |
[8] |
Lin J, Tarr PT, Yang R, Rhee J, Puigserver P, Newgard CB, Spiegelman BM . PGC-1beta in the regulation of hepatic glucose and energy metabolism[J]. J Biol Chem, 2003,278(33):30843-30848
doi: 10.1074/jbc.M303643200 |
[9] |
Yoon JC, Puigserver P, Chen G, Donovan J, Wu Z, Rhee J, Adelmant G, Stafford J, Kahn CR, Granner DK, Newgard CB, Spiegelman BM . Control of hepatic gluconeogenesis through the transcriptional coactivator PGC-1[J]. Nature, 2001,413(6852):131-138
doi: 10.1038/35093050 |
[10] | Pei Q, Wang XS, Wang XB . Study progress of pathogenesis of non-alcoholic steatohepatitis[J]. Lin Chuang Gan Dan Bing Za Zhi, 2008,24(4):304-306 |
裴强, 王晓素, 王宪波 . 非酒精性脂肪性肝炎发病机制的研究进展[J]. 临床肝胆病杂志, 2008,24(4):304-306 | |
[11] | Yu ZY, Gao P, Shen L, Huang HY, Dan J . Expression of endoplasmic reticulum molecular chaperone GRP94 in human nonalcoholic fatty liver and its clinical significance[J]. Shi Jie Hua Ren Xiao Hua Za Zhi, 2008,16(31):3566-3570 |
俞泽元, 高鹏, 申力, 黄海云, 但杰 . 内质网分子伴侣糖调节蛋白94在非酒精性脂肪肝中的表达及意义[J]. 世界华人消化杂志, 2008,16(31):3566-3570 | |
[12] |
Ji C . Dissection of endoplasmic reticulum stress signaling in alcoholic and non-alcoholic liver injury[J]. J Gastroenterol Hepatol, 2008,23(Suppl 1):S16-S24
doi: 10.1111/j.1440-1746.2007.05276.x |
[13] | Gu XH, Zhang YD, Feng AJ . Expression of uncoupling protein 2 in nonalcoholic fatty liver of rats[J]. Shi Jie Hua Ren Xiao Hua Za Zhi, 2005,13(19):2310-2313 |
顾小红, 张云东, 冯爱娟 . 解偶联蛋白-2在大鼠非酒精性脂肪肝中的表达[J]. 世界华人消化杂志, 2005,13(19):2310-2313 | |
[14] | Wang CH, Chen DF . The role of mitochondrial permeability transition pore in apoptosis of non-alcoholic fatty liver cells[J]. Chongqing Yi Xue, 2007,36(8):714-715 |
王春华, 陈东风 . 线粒体膜通透性转换孔在非酒精性脂肪肝细胞凋亡中的作用[J]. 重庆医学, 2007,36(8):714-715 | |
[15] | Nan YM, Qiao L, Yu J, Wu WJ, Yao XX . Fas and its ligand in inducing liver cell apoptosis of non-alcoholic steatohepatitis[J]. Zhonghua Xiao Hua Za Zhi, 2006,26(12):841-842 |
南月敏, 乔梁, 于君, 吴文娟, 姚希贤 . Fas及其配体诱导非酒精性脂肪性肝炎肝细胞凋亡[J]. 中华消化杂志, 2006,26(12):841-842 | |
[16] |
Oh MK, Winn J, Poordad F . Review article: diagnosis and treatment of non-alcoholic fatty liver disease[J]. Aliment Pharmacol Ther, 2008,28(5):503-522
doi: 10.1111/apt.2008.28.issue-5 |
[17] |
Nelson JE, Bhattacharya R, Lindor KD, Chalasani N, Raaka S, Heathcote J, Miskovsky E, Shaffer E, Rulyak SJ, Kowdley KV . HFE C282Y mutations are associated with advanced hepatic fibrosis in Caucasians with nonalcoholic steatohepatitis[J]. Hepatology, 2007,46(3):723-729
doi: 10.1002/(ISSN)1527-3350 |
[18] | Yang JF, Chen ZY, Xiang BK, Yao DG, Yan MX, He BH . Changes of serum leptin in patients with non-alcoholic fatty live[J]. Zhonghua Xiao Hua Za Zhi, 2004,24(12):752-756 |
杨建锋, 陈芝芸, 项柏康, 姚定国, 严茂祥, 何蓓晖 . 非酒精性脂肪肝患者血清瘦素的变化[J]. 中华消化杂志, 2004,24(12):752-756 | |
[19] | Mi XF, Huang ZC, Wang MC, Li SM . Determination of serum iron, transferrin, and ferritin level in nonalcoholic fatty liver patients[J]. Shanghai Yi Yao, 2006,27(11):517-518 |
弭希峰, 黄子成, 王木成, 李水淼 . 非酒精性脂肪肝患者血清铁、转铁蛋白、血清铁蛋白水平测定[J]. 上海医药, 2006,27(11):517-518 | |
[20] |
Kohgo Y, Ohtake T, Ikuta K, Suzuki Y, Torimoto Y, Kato J . Dysregulation of systemic iron metabolism in alcoholic liver diseases[J]. J Gastroenterol Hepatol, 2008,23(Suppl 1):S78-S81
doi: 10.1111/j.1440-1746.2007.05290.x |
[21] |
Bonkovsky HL, Lambrecht RW, Shan Y . Iron as a co-morbid factor in nonhemochromatotic liver disease[J]. Alcohol, 2003,30(2):137-144
doi: 10.1016/S0741-8329(03)00127-7 |
[22] | Li Q, Wang XF, Ma XH . Advancement in correlation study on iron overload and insulin resistance[J]. Yi Xue Zong Shu, 2008,14(13):1932-1934 |
李琪, 王晓峰, 马向华 . 铁超负荷与胰岛素抵抗的相关性研究进展[J]. 医学综述, 2008,14(13):1932-1934 | |
[23] |
Nakagawa T, Muramoto Y, Hori M, Mihara S, Marubayashi T, Nakagawa K . A preliminary investigation of the association between haptoglobin polymorphism, serum ferritin concentration and fatty liver disease[J]. Clin Chim Acta, 2008,398(1-2):34-38
doi: 10.1016/j.cca.2008.08.004 |
[24] |
Trombini P, Piperno A . Ferritin, metabolic syndrome and NAFLD: elective attractions and dangerous liaisons[J]. J Hepatol, 2007,46(4):549-552
doi: 10.1016/j.jhep.2007.01.004 |
[25] | Xu ZJ, Fan JG, Wang XP, Wang GL . Upregulating expressions of hepatic lipopolysaccharide receptors in nonalcoholic steatohepatitic rats[J]. Zhonghua Gang Zang Bing Za Zhi, 2006,14(1):49-52 |
徐正捷, 范建高, 王兴鹏, 王国良 . 非酒精性脂肪性肝炎大鼠肝脏内毒素受体表达上调[J]. 中华肝脏病杂志, 2006,14(1):49-52 | |
[26] |
Huang S, Czech MP . The GLUT4 glucose transporter[J]. Cell Metab, 2007,5(4):237-252
doi: 10.1016/j.cmet.2007.03.006 |
[27] |
Harrison SA, Fincke C, Helinski D, Torgerson S, Hayashi P . A pilot study of orlistat treatment in obese non-alcoholic steatohepatitis patients[J]. Aliment Pharmacol Ther, 2004,20(6):623-628
doi: 10.1111/apt.2004.20.issue-6 |
[28] | Rodgers JT, Puigserver P . Fasting-dependent glucose and lipid metabolic response through hepatic sirtuin 1[J]. Aliment Pharmacol Ther, 2007,104(31):12861-12866 |
[29] | Chen R, Guo Q, Zhu WJ, Xie Q, Wang H, Cai W . Therapeutic efficacy of ω-3 polyunsaturated fatty acid capsule in treatment of patients with non-alcoholic fatty liver disease[J]. Shi Jie Hua Ren Xiao Hua Za Zhi, 2008,16(18):2002-2006 |
陈榕, 郭清, 朱文静, 谢青, 王晖, 蔡伟 . ω-3多不饱和脂肪酸胶丸对非酒精性脂肪肝患者的治疗作用[J]. 世界华人消化杂志, 2008,16(18):2002-2006 | |
[30] |
Capanni M, Calella F, Biagini MR, Genise S, Raimondi L, Bedogni G, Svegliati-Baroni G, Sofi F, Milani S, Abbate R, Surrenti C, Casini A . Prolonged n-3 polyunsaturated fatty acid supplementation ameliorates hepatic steatosis in patients with non-alcoholic fatty liver disease: a pilot study[J]. Aliment Pharmacol Ther, 2006,23(8):1143-1151
doi: 10.1111/apt.2006.23.issue-8 |
[31] | Fan JG . Prevention and treatment of fatty liver by integrative medicine[J]. Zhongguo Zhong Xi Yi Jie He Za Zhi, 2007,27(4):294-295 |
范建高 . 脂肪肝的中西医结合防治[J]. 中国中西医结合杂志, 2007,27(4):294-295 | |
[32] | Wang J, Chen DF . Study progress of the relationship between Sirt1 and non-alcoholic fatty liver disease[J]. Chongqing Yi Xue, 2009,38(4):425-426 |
王军, 陈东风 . Sirt1与非酒精性脂肪性肝病关系的研究进展[J]. 重庆医学, 2009,38(4):425-426 | |
[33] | Yu YQ, Chen HJ . Efficacy observation of prostaglandin E1 in treatment of elderly fatty liver disease[J]. Shi Yong Lao Nian Yi Xue, 2000,14(2):92-93 |
于艳秋, 陈海江 . 前列腺素E1治疗老年脂肪肝疗效观察[J]. 实用老年医学, 2000,14(2):92-93 | |
[34] |
Miller ER 3rd, Pastor-Barriuso R, Dalal D, Riemersma RA, Appel LJ, Guallar E . Meta-analysis: high-dosage vitamin E supplementation may increase all-cause mortality[J]. Ann Intern Med, 2005,142(1):37-46
doi: 10.7326/0003-4819-142-1-200501040-00110 |
[35] | Neuner P, Klosner G, Schauer E, Pourmojib M, Macheiner W, Grunwald C, Knobler R, Schwarz A, Luger TA, Schwarz T . Pentoxifylline in vivo down-regulates the release of IL-1beta, IL-6, IL-8 and tumour necrosis factor-alpha by human peripheral blood mononuclear cells[J]. Immunology, 1994,83(2):262-267 |
[36] |
Facchini FS, Hua NW, Stoohs RA . Effect of iron depletion in carbohydrate-intolerant patients with clinical evidence of nonalcoholic fatty liver disease[J]. Gastroenterology, 2002,122(4):931-939
doi: 10.1053/gast.2002.32403 |
[37] | Zheng J . Study on the changes of TG, CHOT, LDL, ALT in serum of fatty liver suffering with intestinal dysbacteriosis[J]. Zhongguo Wei Sheng Tai Xue Za Zhi, 2007,19(2):161-162 |
郑军 . 肠道菌群失调与脂肪肝患者血脂和丙氨酸氨基转移酶的变化研究[J]. 中国微生态学杂志, 2007,19(2):161-162 | |
[38] |
Higashiyama R, Inagak Y, Hong YY, Kushida M, Nakao S, Niioka M, Watanabe T, Okano H, Matsuzaki Y, Shiota G, Okazaki I . Bone marrow derived cells express matrix metalloproteinases and contribute to regression of liver fibrosis in mice[J]. Hepatology, 2007,45(1):213-222
doi: 10.1002/(ISSN)1527-3350 |
[39] | Xu XZ, Chen B, Ni Y . Study the effect of transplant with bone marrow mesenchymal stem cells(MSCs) on the rat liver fibrosis model induced by carbon tetrachloride(CCl4)[J]. Zhongguo Re Dai Bing Yi Xue, 2008,8(1):16-18 |
徐献忠, 陈斌, 倪勇 . 大鼠干细胞移植对四氯化碳所致大鼠肝硬化的影响[J]. 中国热带病医学, 2008,8(1):16-18 | |
[40] | Shi JP, Xiang BK, Chen ZY . The role of PPARγ in non-alcoholic fatty liver disease[J]. Yi Xue Yan Jiu Za Zhi, 2006,35(1):57-59 |
施军平, 项柏康, 陈芝芸 . PPARγ在非酒精性脂肪性肝病中的作用[J]. 医学研究杂志, 2006,35(1):57-59 | |
[41] |
Di Marzo V, Matias I . Endocannabinoid control of food intake and energy balance[J]. Nat Neurosci, 2005,8(5):585-589
doi: 10.1038/nn1457 |
[42] |
Daubioul CA, Horsmans Y, Lambert P, Danse E, Delzenne NM . Effects of oligofructose on glucose and lipid metabolism in patients with non-alcoholic steatohepatitis: results of a pilot study[J]. Eur J Clin Nutr, 2005,59(5):723-726
doi: 10.1038/sj.ejcn.1602127 |
[43] | Ye F, Zhao WX . Research status quo of non-alcoholic fatty liver in traditional Chinese medicine[J]. Zhongguo Zhong Xi Yi Jie He Xiao Hua Za Zhi, 2003,11(1):60-62 |
叶放, 赵文霞 . 中医对非酒精性脂肪肝的研究现状[J]. 中国中西医结合消化杂志, 2003,11(1):60-62 | |
[44] | Chen W, Wu KY . Study progress of fatty live disease in traditional Chinese medicine[J]. Zhong Yi Yao Tong Bao, 2008,7(4):64-66 |
陈玮, 吴宽裕 . 脂肪肝的中医药研究进展[J]. 中医药通报, 2008,7(4):64-66 | |
[45] | Zhang X, Liu Q, Ma GY . Clinical observation of Zhigan Decoction in treatment of 38 cases of fatty liver disease[J]. Zhonghua Ming Yi Lun Tan, 2005,( 1):22-23 |
张希, 刘清, 马桂英 . 脂肝煎治疗脂肪肝38例临床观察[J]. 中华名医论坛, 2005,( 1):22-23 | |
[46] | Chen XY, Zhao H, Shen M, Jiang SH . Effects of Tiaozhisan Capsule in treatment of 46 senile hyperlipidemia cases of fatty liver disease[J]. Shi Yong Zhong Yi Nei Ke Za Zhi, 2003,17(4):311 |
陈晓云, 赵红, 沈梅, 姜松鹤 . 调脂散胶囊治疗老年高脂血症性脂肪肝46例[J]. 实用中医内科杂志, 2003,17(4):311 | |
[47] | Peng LS, He JS, Zhou DQ, Gao H, Zhou XM, Li WX, Tong GD, Chen L . Mechanisms of therapy for invigorating spleen, promoting digestion to remove food retention and promoting blood circulation in prevention and treatment of fatty liver disease in rats[J]. Zhong Yi Yan Jiu, 2006,19(3):17-19 |
彭立生, 贺劲松, 周大桥, 高辉, 周小梅, 李伟雄, 童光东, 陈亮 . 健脾消导、活血化瘀法对大鼠脂肪肝防治作用的机制研究[J]. 中医研究, 2006,19(3):17-19 | |
[48] | Zhang H, Feng Q, Hu YY, Liu CH, Liu P . Prevention and treatment of “Qushi Huayu Decoction” on fatty liver of rats induced by carbon tetrachloride along with high-fat and low-protein diet[J]. Shanghai Zhong Yi Yao Za Zhi, 2006,40(3):52-55 |
张慧, 冯琴, 胡义扬, 刘成海, 刘平 . 祛湿化瘀方对CCl4复合高脂低蛋白饮食诱导的大鼠脂肪肝的防治作用[J]. 上海中医药杂志, 2006,40(3):52-55 | |
[49] | Chen GF, Cheng Y, Zhou Y, Shen L, Xu LM . Intervening effect of Danze Jiangzhi decoction(DZJZ) on the non-alcoholic fatty liver disease in rats[J]. Zhong Xi Yi Jie He Gan Bing Za Zhi, 2007,17(4):214-216 |
陈高峰, 成扬, 周扬, 沈丽, 徐列明 . 丹泽降脂方防治大鼠非酒精性脂肪肝的实验研究[J]. 中西医结合肝病杂志, 2007,17(4):214-216 | |
[50] | Feng R . Clinical observation of Huoxue Jiangzhi Tiaogan Decoction in treatment of 39 cases of fatty liver disease[J]. Sichuang Zhong Yi, 2006,24(12):61-62 |
冯蓉 . 活血降脂调肝汤治疗脂肪肝39例临床观察[J]. 四川中医, 2006,24(12):61-62 | |
[51] | Cheng LB, Zhang CZ . Jiangzhi Yigan Decoction in treatment of 32 cases of fatty liver disease[J]. Zhong Xi Yi Jie He Gan Bing Za Zhi, 2005,15(3):179-180 |
程良斌, 张赤志 . 降脂益肝汤治疗脂肪肝32例[J]. 中西医结合肝病杂志, 2005,15(3):179-180 | |
[52] | Huang DY, Yao DP, Zhu ZY . Clinical observation of Huzhang Jiangzhi Decoction and auricular pressing in treatment of 80 cases of fatty liver disease[J]. Jiangsu Zhong Yi Yao, 2008,40(4):44-45 |
黄德亚, 姚东坡, 朱志义 . “虎杖降脂汤”内服结合耳穴按压法治疗脂肪肝80例临床观察[J]. 江苏中医药, 2008,40(4):44-45 | |
[53] | Ming YH . Medicine-separated moxibustion cake combined with drugs in treatment of 81 cases of simple non-alcoholic fatty liver[J]. Zhong Xi Yi Jie He Gan Bing Za Zhi, 2008,18(3):172-173 |
明玉华 . 隔药饼灸联合药物治疗非酒精性单纯性脂肪肝81例[J]. 中西医结合肝病杂志, 2008,18(3):172-173 | |
[54] | Wang J, Zhang CY, Cheng L, Chen LQ . Clinical observation of electro-acupuncture plus ear-acupuncture in treating 30 cases of obese fatty liver[J]. Shanghai Zhong Yi Yao Za Zhi, 2006,40(7):41-42 |
王骏, 张春燕, 程玲, 陈利群 . 健脾法电针配合耳穴治疗肥胖性脂肪肝30例临床观察[J]. 上海中医药杂志, 2006,40(7):41-42 | |
[55] | Liu YP, Liu SS, Ma XQ . Clinical observation of Xiaozhi Decoction with acupuncture in treatment of 90 cases of fatty liver[J]. Zhen Jiu Lin Chuang Za Zhi, 2007,23(2):9-10 |
刘亚平, 刘树山, 马秀琴 . 消脂汤配合针灸治疗脂肪肝90例的临床观察[J]. 针灸临床杂志, 2007,23(2):9-10 | |
[56] | Jin JJ, Xu YL, Zheng Y . Effects of acupoint-injection of Kaixilai on TG, TC, MDA, SOD, AST and ALT in the patient of non-alcoholic fatty liver[J]. Zhongguo Zhen Jiu, 2006,26(2):100-102 |
金建军, 徐亚莉, 郑昱 . 穴位注射对非酒精性脂肪肝血脂代谢及肝功能的影响[J]. 中国针灸, 2006,26(2):100-102 | |
[57] | Zhou L, Lin GQ, Pang CX, Pang Y . Observation of the therapeutic effects on fatty liver by acupuncture combined with intravenous drip of Xueshuantong injection[J]. Hebei Zhong Yi, 2008,30(9):961-962 |
周丽, 林桂权, 庞崇祥, 庞燕 . 针刺配合血栓通注射液治疗脂肪肝疗效观察[J]. 河北中医, 2008,30(9):961-962 | |
[58] |
Bugianesi E, Leone N, Vanni E, Marchesini G, Brunello F, Carucci P, Musso A, Paolis D, Capussotti L, Salizzoni M, Rizzetto M . Expanding the natural history of nonalcoholic steatohepatitis: from cryptogenic cirrhosis to hepatocellular carcinoma[J]. Gastroenterology, 2002,123(1):134-140
doi: 10.1053/gast.2002.34168 |
[59] |
Uraz S, Aygun C, Sonsuz A, Ozbay G . Serum iron levels and hepatic iron overload in nonalcoholic steatohepatitis and chronic viral hepatitis[J]. Dig Dis Sci, 2005,50(5):964-969
doi: 10.1007/s10620-005-2672-z |
[1] | Ye-juan Jia, Tian-yu Li, Peng Han, Yu Chen, Li-jia Pan, Chun-sheng Jia. Effects of different courses of moxibustion treatment on intestinal flora and inflammation of a rat model of knee osteoarthritis. Journal of Integrative Medicine, 2022, 20(2): 173-181. |
[2] | Ning Zhang, Xiao-he Xiao. Integrative medicine in the era of cancer immunotherapy: Challenges and opportunities. Journal of Integrative Medicine, 2021, 19(4): 291-294. |
[3] | Arthur Yin Fan, Hui Ouyang, Xinru Qian, Hui Wei, David Dehui Wang, Deguang He, Haihe Tian, Changzhen Gong, Amy Matecki, Sarah Faggert Alemi. Discussions on real-world acupuncture treatments for chronic low-back pain in older adults. Journal of Integrative Medicine, 2019, 17(2): 71-76. |
[4] | Bruno José Martins Da Silva, Amanda Anastácia Pinto Hage, Edilene Oliveira Silva, Ana Paula Drummond Rodrigues. Medicinal plants from the Brazilian Amazonian region and their antileishmanial activity: A review. Journal of Integrative Medicine, 2018, 16(4): 211-222. |
[5] | Yoshiharu Motoo, Takashi Hakamatsuka, Nobuo Kawahara, Ichiro Arai, Kiichiro Tsutani. Standards of Reporting Kampo Products (STORK) in research articles. Journal of Integrative Medicine, 2017, 15(3): 182-185. |
[6] | Qing Ji, Yun-quan Luo, Wen-hai Wang, Xuan Liu, Qi Li, Shi-bing Su. Research advances in traditional Chinese medicine syndromes in cancer patients. Journal of Integrative Medicine, 2016, 14(1): 12-21. |
[7] | Nobuari Takakura, Miho Takayama, Hiroyoshi Yajima. The difference of park and streitberger single-blind needles from takakura double-blind needle. Journal of Integrative Medicine, 2015, 13(4): 212-214. |
[8] | Chang-quan Ling, Xiao-qiang Yue, Chen Ling. Three advantages of using traditional Chinese medicine to prevent and treat tumor. Journal of Integrative Medicine, 2014, 12(4): 331-335. |
[9] | Feng-bin Liu, Zheng-kun Hou, Yun-ying Yang, Pei-wu Li, Qian-wen Li, Nelson Xie, Jing-wei Li, Xiang-jing Zeng. Literature review and analysis of the application of health outcome assessment instruments in Chinese medicine. Journal of Chinese Integrative Medicine, 2013, 11(3): 157-167. |
[10] | Zhao-lan Liu, Qing Li , Yu-jie Mu , Ying Gao, Jian-ping Liu. Using nested case-control study to appraise the effectiveness of Chinese medicines in the treatment of diabetic nephropathy. Journal of Chinese Integrative Medicine, 2012, 10(9): 991-996. |
[11] | Zhang-ling Zhou, Cheng-xin Li, Yue-bo Jiang, Cong Zuo, Yun Cai, Rui Wang. Correlation between facial nerve functional evaluation and efficacy evaluation of acupuncture treatment for Bell’s palsy. Journal of Chinese Integrative Medicine, 2012, 10(9): 997-1002. |
[12] | Jian-sheng Li, Ya Li, Su-yun Li, Yuan-yuan Wang, Li Deng, Yan-ge Tian, Su-li Jiang , Ying Wang. Long-term effects of Tiaobu Feishen therapies on systemic and local inflammation responses in rats with stable chronic obstructive pulmonary disease. Journal of Chinese Integrative Medicine, 2012, 10(9): 1039-1048. |
[13] | Wei-hua Xu, Ze-huai Wen, Wei-xiong Liang, Qi Wang. A review of research on the development of instruments for therapeutic efficacy evaluation of traditional Chinese medicine. Journal of Chinese Integrative Medicine, 2012, 10(7): 726-737. |
[14] | Ming-xing Zhao, Zhen-hua Dong, Zhong-hai Yu, Shi-yuan Xiao, Ya-ming Li . Effects of Ginkgo biloba extract in improving episodic memory of patients with mild cognitive impairment: A randomized controlled trial. Journal of Chinese Integrative Medicine, 2012, 10(6): 628-634. |
[15] | Li-xin Ma, Yu-yi Wang, Xin-xue Li, Jian-ping Liu . Systematic review on methodology of randomized controlled trials of post-marketing Chinese patent drugs for treatment of type 2 diabetes. Journal of Chinese Integrative Medicine, 2012, 10(3): 279-292. |